key: cord-0997843-xk96xm71
authors: Alyami, Hamad S.; Naser, Abdallah Y.; Dahmash, Eman Zmaily; Alyami, Mohammed H.; Alyami, Musfer S.
title: Depression and anxiety during the COVID‐19 pandemic in Saudi Arabia: A cross‐sectional study
date: 2021-04-27
journal: Int J Clin Pract
DOI: 10.1111/ijcp.14244
sha: 8021d12cd9563d68d9ba6109f1b9f4d61f275dc6
doc_id: 997843
cord_uid: xk96xm71

AIMS: The emergence of the COVID‐19 global pandemic, with a high transmission and mortality rate, has created an extraordinary crisis worldwide. Such an unusual situation may have an undesirable impact on the mental health of individuals which, in turn, may influence their outcomes. This study aimed to explore the influence of the COVID‐19 pandemic on the psychological disposition of residents of the Kingdom of Saudi Arabia. METHODS: A cross‐sectional study using an online survey was conducted in Saudi Arabia between 27 March and 27 April 2020. The Patient Health Questionnaire (PHQ‐9) and Generalised Anxiety Disorder‐7 (GAD‐7) were used to assess depression and anxiety. Logistic regression analysis was used to identify predictors of these. RESULTS: A total of 2081 individuals participated in the study. The prevalence of depression and anxiety among the study participants was 9.4% and 7.3% respectively. Non‐Saudi residents, individuals aged 50 years and above, divorced people, retired people, university students and those with an income between 2000 and 10 000 SR were at higher risk of developing depression. Saudi individuals, married people, the unemployed and those with a high income (>10 000 RS) were at higher risk of developing anxiety. CONCLUSION: We found that there is a wide range of Saudi residents who are at higher risk of developing mental illness during the current COVID‐19 pandemic. Policymakers and mental healthcare providers are advised to provide continuous monitoring of the psychological consequences during this pandemic and provide the required health support.

, which stands for coronavirus disease 2019, is a cluster of three acute respiratory illnesses that first occurred in Wuhan, Hubei Province, China, in December 2019. 1 In early March 2020, the first case of COVID-19 was confirmed in the Kingdom of Saudi Arabia, and since then, it has caused 2017 deaths of the 217 108 patients who were infected with this disease until the 7th of July 2020. [2] [3] [4] The causative agent for COVID-19 has been identified as a new RNA virus from the beta-coronavirus family; its transmission rate is considered high because it is transmitted in different ways, such as respiratory droplets and close contact. The World Health Organization (WHO) has categorised COVID-19 as a pandemic infection since the respiratory illness it causes is highly contagious 5 because of the novelty of the virus, its rapid spread and the lack of therapeutic and preventative strategies. 6 The spread of COVID-19 presents serious risks globally and in Saudi Arabia, which has reported 393 377 cases and 6704 deaths as of 06 April 2021. 7 Saudi Arabia has exceptional circumstances as it is a hub for millions of foreign workers and pilgrims from across the globe. In response to the pandemic and to combat the spread of the disease, the government took swift action and closed the two holy mosques, suspended travel to the country, closed most businesses and limited individuals' movement. Further, the government created a national narrative to encourage citizens to adhere to the emergency measures established in response to the pandemic. 6 The Kingdom of Saudi Arabia took the deadly coronavirus outbreak seriously, even before the Ministry of Health announced the first confirmed COVID-19 case; for example, it announced the temporary suspension of entry to Makkah and Madinah in February 2020. 8 After the first confirmed case, the government announced a series of extreme measures to control the spread of the virus, beginning on 8 March with a ban on all transport in and out of the Qatif Governorate. Then, on 6 April, they announced a 24-hour curfew to be implemented in the major cities, with movement restricted to essential travel between 6 am and 3 pm. 9 The extremely proactive measures taken to prevent the spread of the virus could have provoked other health outcomes usually neglected in crisis and pandemic management. [10] [11] [12] [13] [14] [15] Recent studies have shown that the rapid global growth in the number of COVID-19 cases and deaths, the collapse of the healthcare system in many countries and the subsequent lack of effective medical treatment have had the same effect. [16] [17] [18] COVID-19 is having a severe impact on the physical and mental health of the public 16, [18] [19] [20] [21] ; therefore, we aimed to assess the mental health burden placed on citizens and residents inside the Kingdom of Saudi Arabia at this time, as well as to identify potential populations who may need psychological intervention.

A cross-sectional study using an online survey was conducted in Saudi Arabia between 27 March and 27 April 2020 to explore depression and anxiety among the general population during the COVID-19 pandemic.

A convenience sample of eligible participants drawn from the general population was invited through social media (Facebook and WhatsApp) to participate in the study. All the participants participated voluntarily in the study and were, thus, considered exempt from written informed consent. The study aims and objectives were clearly explained at the beginning of the survey.

The inclusion criteria were as follows: (a) participants aged 18 years and above and living currently in Saudi Arabia, and (b) participants who had no apparent cognitive deficiency. Participants were excluded if they were as follows: (a) below 18 years of age, (b) unable to understand the Arabic language and c) unable to participate because of physical or emotional distress. The inclusion and exclusion criteria were clearly stated in the invitation letter accompanying the questionnaire. Participants were invited to participate if they were eligible.

Previously validated assessment scales, the Patient Health Questionnaire (PHQ)-9 and Generalised Anxiety Disorder sevenitem (GAD-7), were used to assess depression and anxiety among the study participants. These screening instruments have been frequently used and have been validated as brief screening tools among various populations for depression and anxiety. [22] [23] [24] [25] [26] The following information was also collected: the participants' demographics, including age, gender, income, education level, employment status and marital status. Furthermore, participants were asked whether they were worried about being infected with COVID-19 or transmitting it to family members (yes/no question) and whether they had any underlying chronic conditions (yes/no question).

The PHQ-9 scale is a 9-item instrument given to participants to screen for the presence and severity of depression. 27, 28 The GAD-7

instrument was used to screen for anxiety. 29 The PHQ-9 and the GAD-7 instruments asked the participants about the degree of applicability of a range of items (questions), using a 4-point Likert scale.

Participants' responses ranged from 0 to 3, where zero meant "Not at all" and three meant "Nearly every day". The PHQ-9 instrument includes nine items. Items are scored from 0 to 3, generating a total score ranging from 0 to 27. A total score of 0-4 indicates minimal depression, 5-9 mild depression, 10-14 moderate depression, [15] [16] [17] [18] [19] moderately severe depression, and 20-27 severe depression. 30 The GAD-7 instrument includes seven items. Items are scored from 0 to 3, generating a total score ranging from 0 to 21. A total score of 5-9 indicates mild anxiety, 10-14 moderate anxiety and 15-21 severe anxiety. 31 

Prevalence rates of depression and anxiety were determined using a cut-off point, as recommended by the authors of the PHQ-9 and GAD-7 scales. In this study, depression was defined as a total score of ≥15 in the PHQ-9 instrument, indicating a case with moderately severe or severe depression. Anxiety was defined using the GAD-7 instrument with a total score of ≥15, indicating a case of severe anxiety. The higher the score, the more severe the case identified by either scale.

The prevalence rate of depression was estimated by dividing the number of participants who exceeded the borderline score (≥ 15) by the total number of participants in the same population.

The prevalence rate of anxiety was calculated using the same procedure.

The target sample size was estimated based on WHO recommendations for the minimal sample size needed for a prevalence study. 32 Using a confidence interval of 95%, a standard deviation of 0.5 and a margin of error of 5%, the required sample size was 385 participants.

Descriptive statistics were used to describe the participants' demographic characteristics. Continuous data were reported as mean ± SD for normally distributed variables and median (interquartile range (IQR)) for non-normally distributed variables. Categorical data were reported as percentages (frequencies). The Mann-Whitney U test/Kruskal-Wallis test was used to compare the median scores between different demographic groups. Logistic regression was used to estimate the odds ratios (ORs) with 95% confidence intervals (CIs) for anxiety or depression. Logistic regression models were carried out using anxiety (≥15) or depression scores (≥15) above the cutoff points highlighted above. A two-sided P < .05 was considered to be statistically significant. The statistical analyses were carried out using SPSS (version 25).

Ethical approval was obtained from the School of Life and Health

Sciences at Najran University, Najran, Saudi Arabia (27/03/2020ET).

As participation in the study was voluntary and the study was on the general public without any intervention, meaning that it involved no more than minimal risk, the Research Ethics Committee approved a consent waiver.

A total of 2081 individuals participated in the study. Table 1 previous 2 weeks, and the extent to which these problems had prevented them from doing their work, looking after their household affairs or dealing with people, around half of them (n = 1053, 50.6%)

reported that they faced difficulties.

The prevalence of depression among the participants was 9.4%

(n = 196). The proportions of minimal, mild, moderate, moderately severe and severe depression were 29.6%, 40.9%, 20%, 6.2% and 3.2% respectively. The prevalence of anxiety among the participants was 7.3% (n = 151). The proportions of mild, moderate and severe anxiety were 73.5%, 19.3% and 7.3% respectively. Tables 2 and 3 detail the prevalence of depression and anxiety among the participants, stratified by severity and gender respectively. Table 5 . 10 000 SR and above 6.00 6.00 6.00 5.00

Abbreviation: IQR, interquartile range. reported that the prevalence of minor mental illness was significantly higher in women (22.2%) than men (13.7%) (P = .0073). 38 This confirms what has been reported in a previous meta-analysis that explored the prevalence of depression across 30 countries all over the world between 1994 and 2014. In this study, women showed higher depression rates compared with men: 14.4% (95% CI: 11.1%-11.7%) for women and 11.5% (95% CI: 9%-14.6%) for men. 39 Further, the prevalence rate was higher in the younger age group, which agrees with our study, as a higher score of depression was This was in addition to their lack of confidence in distance learning.

The lockdown and social distancing are expected to remain in place for some time to come, and this will have a direct effect on lowincome and unemployed individuals 41 ; this might put such categories under a higher level of stress, which could lead to symptoms of anxiety and/or depression. Second, because of the sudden occurrence of the outbreak, an individual's anxiety and depression prevalence before the outbreak could not be gauged. Third, the survey was administered at a single period and so the stability of the responses is unknown. The study design itself, a cross-sectional survey design, limited our ability to identify causality between study variables, unlike a recent longitudinal study that was conducted in China which was able to monitor the change in psychological status among the general population across different time points of the pandemic. 45 Fourth, the sample may be biased as those who were more interested in mental health or distressed by the pandemic may have been more likely to participate.

Finally, this study mainly used self-reported questionnaires to measure psychiatric symptoms and did not make clinical diagnoses. The gold standard for establishing psychiatric diagnosis involves structured clinical interviews and functional neuroimaging. 46,47

During the initial phase of the COVID-19 pandemic in Saudi Arabia, more than 29% of the respondents had moderate-to-severe depression, and 26.6% reported moderate-to-severe anxiety. Female gender, student status, low-income and low education level respondents were associated with a greater psychological impact of the outbreak, and higher levels of anxiety and depression. Our findings may enable policymakers to introduce several measures and psychological interventions that can enhance mental health during the current pandemic.

This study appears on a preprint server (medrxiv): https://www. medrx iv.org/conte nt/10.1101/2020.05.09.20096 677v1.

The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Data sharing is not applicable to this article as no new data were created or analysed in this study.

Abdallah Y. Naser https://orcid.org/0000-0001-8440-7446

Eman Zmaily Dahmash https://orcid.org/0000-0002-9815-3720

Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China

Novel Coronavirus Map

Coronavirus Worldwide Data

Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: an ecological study

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19

Coronavirus disease-2019 pandemic in the Kingdom of Saudi Arabia: Mitigation measures and hospital preparedness

COVID-19 Coronavirus Pandemic

Saudi Arabia temporarily suspends entry of GCC citizens to Mecca and Medina: foreign ministry

Coronavirus: Saudi Arabia imposes 24-hour curfew in several cities, including Riyadh

The psychological impact of the COVID-19 epidemic on college students in China

Mental health care for medical staff in China during the COVID-19 outbreak

Nursing and complex humanitarian emergencies: Ebola is more than a disease

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a webbased cross-sectional survey

Mental health care for international Chinese students affected by the COVID-19 outbreak

Understanding the factors influencing healthcare providers' burnout during the outbreak of COVID-19 in Jordanian hospitals

Mental health status of healthcare professionals and students of health sciences faculties in Kuwait during the COVID-19 pandemic

The effect of the 2019 coronavirus disease outbreak on social relationships: a cross-sectional study in Jordan

Mental health status of the general population, healthcare professionals, and university students during 2019 coronavirus disease outbreak in Jordan: a cross-sectional study

Anxiety and depression among people under the nationwide partial lockdown in Vietnam

Psychological impact of COVID-19 pandemic in the Philippines

Impact of COVID-19 pandemic on mental health in the general population: a systematic review

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis

Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population

Depression: Screening and diagnosis

Usefulness of the Patient Health Questionnaire-9 for Korean medical students

Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population

Assessment of depression severity with the PHQ-9 in cancer patients and in the general population

The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer

The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients

UMHS Depression Guideline

A brief measure for assessing generalized anxiety disorder: the GAD-7

World Health Organization. Sample size determination in health studies: a practical manual

Centre for Disease Control and Prevention

Iranian mental health during the COVID-19 epidemic

A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations

Ministry of Health Saudi Arabia

Occupational Safety and Health Administration. COVID-19 Control and Prevention

Prevalence of mental illness among Saudi adult primary-care patients in Central Saudi Arabia

Prevalence of depression in the community from 30 countries between

Why is depression more prevalent in women?

What will be the economic impact of COVID-19 in the US? Rough estimates of disease scenarios

Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic

The cost effective solution for internet cognitive behavioral therapy (I-CBT) interventions. Technol Health Care

Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials

A longitudinal study on the mental health of general population during the COVID-19 epidemic in China

Diagnostic and predictive applications of functional near-infrared spectroscopy for major depressive disorder: a systematic review

Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder